• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国实施法定健康保险覆盖 HIV 暴露前预防费用后 HIV 感染者的性传播疾病。

Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.

机构信息

Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.

Institute of Biostatistics and Mathematical Modelling, Goethe University Frankfurt, Frankfurt am Main, Germany.

出版信息

HIV Med. 2023 Feb;24(2):163-169. doi: 10.1111/hiv.13353. Epub 2022 Jul 20.

DOI:10.1111/hiv.13353
PMID:35859321
Abstract

OBJECTIVES

After pre-exposure prophylaxis (PrEP) was introduced, rates of sexually transmitted infections (STIs) increased among PrEP users. However, data on STI trends in people living with HIV since then are limited. Since September 2019, PrEP has been covered by statutory German health insurance (SHI) in vulnerable groups. This study aimed to determine whether this coverage of PrEP costs affected STI rates in people living with HIV (specifically, men who have sex with men).

METHODS

All patients of the HIVCENTER Frankfurt diagnosed with at least one STI within the observation period were retrospectively enrolled in the study. STIs included infection with Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, and/or Trichomonas vaginalis. The observation period covered 1 year before and 1 year after the coverage of PrEP costs by German SHI. Data were collected from outpatient clinic records.

RESULTS

In total, 143 patients were enrolled in the study. The observation period was September 2018 to August 2019 for group 1 (n = 73) and September 2019 to August 2020 for group 2 (n = 70). The most frequent STIs were syphilis and infections due to chlamydia, gonococci, and trichomonads, in descending order. Infections with T. pallidum occurred more often in group 2 than in group 1 (60.0% vs. 50.7%; p = 0.253) as did chlamydia (37.1% vs. 28.8%; p = 0.286).

CONCLUSIONS

A tendency for an increased ratio of STIs in people living with HIV was observed after the introduction of PrEP coverage by German SHI. STIs should be discussed intensively with people living with HIV, since the communities of PrEP users and people living with HIV overlap, and changes in risk behaviour might influence both groups.

摘要

目的

暴露前预防(PrEP)推出后,PrEP 使用者的性传播感染(STI)率有所上升。然而,此后关于 HIV 感染者的 STI 趋势的数据有限。自 2019 年 9 月以来,PrEP 已被德国法定健康保险(SHI)覆盖弱势群体。本研究旨在确定 PrEP 费用的覆盖是否影响了 HIV 感染者(特别是男男性行为者)的 STI 率。

方法

在观察期内,所有在法兰克福 HIV 中心诊断出至少一种 STI 的患者均被纳入研究。STIs 包括梅毒螺旋体、沙眼衣原体、淋病奈瑟菌和/或阴道毛滴虫感染。观察期包括德国 SHI 覆盖 PrEP 费用之前的 1 年和之后的 1 年。数据来自门诊记录。

结果

共有 143 名患者纳入研究。第 1 组的观察期为 2018 年 9 月至 2019 年 8 月(n=73),第 2 组为 2019 年 9 月至 2020 年 8 月(n=70)。最常见的 STIs 依次为梅毒、衣原体、淋病和滴虫感染。第 2 组的梅毒感染率高于第 1 组(60.0% vs. 50.7%;p=0.253),衣原体感染率也高于第 1 组(37.1% vs. 28.8%;p=0.286)。

结论

在德国 SHI 引入 PrEP 覆盖后,HIV 感染者的 STI 比例呈上升趋势。由于 PrEP 用户和 HIV 感染者的群体重叠,因此应该与 HIV 感染者深入讨论 STIs,因为行为风险的变化可能会影响这两个群体。

相似文献

1
Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.德国实施法定健康保险覆盖 HIV 暴露前预防费用后 HIV 感染者的性传播疾病。
HIV Med. 2023 Feb;24(2):163-169. doi: 10.1111/hiv.13353. Epub 2022 Jul 20.
2
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.2020 年德国接受暴露前预防(PrEP)的人群中 HIV 感染和性传播感染发病率较低。
Infection. 2023 Jun;51(3):665-678. doi: 10.1007/s15010-022-01919-3. Epub 2022 Sep 27.
3
[Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections].[评估将艾滋病病毒暴露前预防作为法定医疗保险福利(EvE-PrEP)的引入:对艾滋病病毒的高效保护且不会增加性传播感染]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Sep;66(9):1008-1018. doi: 10.1007/s00103-023-03733-0. Epub 2023 Jul 12.
4
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.2018 年至 2019 年,在以男男性行为者为主的高感染率人群中,HIV 暴露前预防并未对性传播感染的流行率产生影响,德国。
Euro Surveill. 2022 Apr;27(14). doi: 10.2807/1560-7917.ES.2022.27.14.2100591.
5
Routine Data Analysis of HIV Pre-Exposure Prophylaxis Use and Rates of Sexually Transmitted Infections Since Coverage of HIV Pre-Exposure Prophylaxis by the Statutory Health Insurance in Germany.德国法定健康保险覆盖 HIV 暴露前预防措施后,HIV 暴露前预防措施使用和性传播感染率的常规数据分析。
Arch Sex Behav. 2024 Oct;53(9):3663-3672. doi: 10.1007/s10508-024-02922-5. Epub 2024 Aug 6.
6
Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.定量评估男男性行为者在暴露前预防措施前后性行为和性传播感染分布的异质性。
Sex Transm Infect. 2022 Sep;98(6):395-400. doi: 10.1136/sextrans-2021-055227. Epub 2021 Oct 29.
7
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.在使用 PrEP 的情况下的性传播感染:德国男男性行为者中不同解剖部位的衣原体、淋病和支原体的高流行率。
BMC Infect Dis. 2020 Feb 7;20(1):110. doi: 10.1186/s12879-020-4831-4.
8
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.每日用药和按需用药预防方案下男男性行为者的性行为特征和艾滋病毒及性传播感染发病率:AMPrEP 研究两年结果。
Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6.
9
Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.肯尼亚女性使用 HIV 暴露前预防药物(PrEP)的特征:一项关于多西环素用于性传播感染预防的随机试验。
BMC Womens Health. 2023 Jun 3;23(1):296. doi: 10.1186/s12905-023-02413-0.
10
Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.檀香山预防性暴露前预防 HIV 感染使用者的性传播感染事件案例。
Hawaii J Health Soc Welf. 2021 Jul;80(7):148-154.